Oruka Therapeutics, Inc. Public Float
Oruka Therapeutics, Inc. (ORKA) had Public Float of $371.50 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $371.50M.
- 2024-06-30: Entity Public Float $39.70M.
- 2023-06-30: Entity Public Float $20.91M.
- 2022-06-30: Entity Public Float $29.19M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $371.50M 10-K · filed 2026-03-12 |
| 2024-06-30 | $39.70M 10-K · filed 2025-03-06 |
| 2023-06-30 | $20.91M 10-K · filed 2024-02-01 |
| 2022-06-30 | $29.19M 10-K · filed 2023-02-24 |
| 2021-06-30 | $50.09M 10-K · filed 2022-03-14 |
| 2020-06-30 | $14.95M 10-K · filed 2021-03-18 |
| 2019-06-28 | $10.59M 10-K · filed 2020-02-18 |
| 2018-06-29 | $7.65M 10-K · filed 2019-02-27 |
| 2017-06-30 | $13.81M 10-K · filed 2018-03-22 |
| 2016-06-30 | $13.79M 10-K · filed 2017-03-21 |
| 2015-06-30 | $47.90M 10-K · filed 2016-03-17 |
| 2014-06-30 | $30.00M 10-K · filed 2015-03-19 |
| 2013-06-28 | $12.06M 10-K · filed 2014-03-20 |
| 2012-06-29 | $5.85M 10-K · filed 2013-03-21 |
| 2011-06-30 | $14.19M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |